文献速递心血管儿科影像CTMR

川崎病冠状动脉周围脂肪组织CT衰减及其与冠状动脉瘤、心肌灌注和冠状动脉事件的相关性

Pericoronary Adipose Tissue CT Attenuation in Kawasaki Disease and Association with Coronary Artery Aneurysms, Myocardial Perfusion, and Coronary Events.
PubMed 文献 · Radiol Cardiothorac Imaging · 2025-01-01

这项回顾性研究纳入100例川崎病患者和35名健康对照,评估冠状动脉周围脂肪组织CT衰减与冠状动脉瘤、心肌灌注及未来冠状动脉事件的关系。结果显示冠状动脉瘤患者PCAT衰减更高,且PCAT衰减与心肌灌注指数负相关,并可独立预测冠状动脉事件发生。

要点

  • 川崎病患者中,存在冠状动脉瘤者PCAT CT衰减高于无冠状动脉瘤者及健康对照。
  • PCAT CT衰减与整体心肌灌注指数呈负相关。
  • PCAT CT衰减和最大冠状动脉瘤Z评分均可独立预测冠状动脉事件。

核心结论

  • 在川崎病患者中,较高的平均PCAT CT衰减与冠状动脉瘤存在及心肌灌注减低相关,并可独立预测冠状动脉事件的发生。

研究设计与样本

  • 回顾性研究,纳入100例川崎病患者和35名健康对照,均行冠状动脉CT血管成像,部分患者于CCTA后2周内行心脏MRI。

诊断标准与关键数值

  • 有冠状动脉瘤患者(n=64)平均PCAT CT衰减为-67.1 HU ± 6.4,无冠状动脉瘤患者(n=36)为-75.0 HU ± 8.6,健康对照为-77.0 HU ± 8.5,均有冠状动脉瘤者高于无冠状动脉瘤者及健康对照(均P < .001)。
  • 冠状动脉瘤存在与平均PCAT CT衰减独立相关(β = 7.20;P < .001)。
  • 平均PCAT CT衰减与整体心肌灌注指数呈负相关(n = 18;r = -0.50;P = .02)。
  • 平均PCAT CT衰减预测冠状动脉事件的OR为1.20(95%CI:1.00,1.30;P = .007)。
  • 最大冠状动脉瘤Z评分预测冠状动脉事件的OR为1.30(95%CI:1.10,1.50;P = .01)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate coronary inflammation using pericoronary adipose tissue (PCAT) CT attenuation in patients with Kawasaki disease (KD) and determine the association of PCAT CT attenuation with coronary artery aneurysm (CAA), myocardial perfusion, and future coronary events (CEs). Materials and Methods This retrospective study included patients with KD and healthy controls who underwent coronary CT angiography (CCTA). Some patients also underwent cardiac MRI within 2 weeks of CCTA. Patients were split into subgroups according to presence or absence of CAA. PCAT CT attenuation and cardiac MRI-based myocardial perfusion were measured. CEs, including coronary artery thrombosis, obstruction, stenosis, procedural events, and acute ischemic events, were recorded. Associations were assessed using univariable and multivariable regression analyses and Spearman correlation analysis. Results One hundred patients with KD (mean age, 7.5 years ± 3.6 [SD]; 79 male) and 35 healthy controls (mean age, 8.4 years ± 2.8; 18 male) were included. Mean PCAT CT attenuation was higher in patients with CAA (n = 64) than in patients without CAA (n = 36) and healthy controls (-67.1 HU ± 6.4 vs -75.0 HU ± 8.6 and -77.0 HU ± 8.5, respectively; both P < .001). CAA presence (β = 7.20; P < .001) was independently associated with mean PCAT CT attenuation. Mean PCAT CT attenuation was negatively correlated with the global myocardial perfusion index (n = 18; r = -0.50; P = .02). During a median follow-up period of 19.7 months, 18 of 100 patients (18%) experienced CEs. Both mean PCAT CT attenuation (odds ratio [OR], 1.20 [95% CI: 1.00, 1.30]; P = .007) and the Z-score of the largest CAA (OR, 1.30 [95% CI: 1.10, 1.50]; P = .01) independently predicted CE occurrence. Conclusion In patients with KD, higher mean PCAT CT attenuation was associated with CAA presence and decreased myocardial perfusion and independently predicted occurrence of CEs. Keywords: Kawasaki Disease, Coronary CT Angiography, Pericoronary Adipose Tissue CT Attenuation, Coronary Artery Aneurysm, Myocardial Perfusion, Coronary Events Clinical trial registration no. ChiCTR2300076398 Supplemental material is available for this article. © RSNA, 2025.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Azhe S, Hu L, Zhou Z, et al. Pericoronary Adipose Tissue CT Attenuation in Kawasaki Disease and Association with Coronary Artery Aneurysms, Myocardial Perfusion, and Coronary Events. Radiol Cardiothorac Imaging. 2025. PMID: 40569153. doi:10.1148/ryct.240303

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。